Related Experiment Video
Updated: Mar 17, 2026

Evaluation of LC3-II Release via Extracellular Vesicles in Relation to the Accumulation of Intracellular LC3-positive Vesicles
Published on: October 18, 2024
UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome
Roland Hjerpe1, John S Bett1, Matthew J Keuss2
1Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, Davidson Building, Henry Wellcome Lab of Cell Biology, University of Glasgow, G12 8QQ Glasgow, UK; The MRC Protein Phosphorylation and Ubiquitylation Unit, The Sir James Black Centre, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, Scotland.
Protein clearance is vital for cell survival. A new pathway uses UBQLN2 and HSP70 to remove protein aggregates via the proteasome, with mutations causing neurodegeneration.
Area of Science:
- Cellular biology
- Molecular mechanisms of protein degradation
- Neuroscience
Background:
- Protein homeostasis is crucial for cell survival.
- Misfolded and aggregated proteins can be toxic.
- The 26S proteasome degrades ubiquitylated proteins, but other pathways exist.
Purpose of the Study:
- To investigate the role of proteasome shuttle factors in protein aggregate clearance.
- To elucidate the mechanism by which UBQLN2 contributes to protein homeostasis.
- To understand the link between UBQLN2 dysfunction and neurodegeneration.
Main Methods:
- Investigated the interaction between UBQLN2, HSP70, and the 26S proteasome.
- Examined protein aggregate clearance in cellular models.
- Assessed the impact of UBQLN2 mutations on chaperone binding and aggregate clearance.
- Studied cognitive deficits in mouse models with UBQLN2 mutations.
Main Results:
- UBQLN2 acts with HSP70-HSP110 disaggregase machinery to clear protein aggregates via the 26S proteasome.
- UBQLN2 recognizes client-bound HSP70 and facilitates protein degradation.
- This nuclear clearance pathway is distinct from autophagy.
- Human UBQLN2 mutations impair chaperone binding, aggregate clearance, and cause cognitive deficits in mice.
Conclusions:
- UBQLN2 mediates a novel pathway for clearing protein aggregates in the nucleus.
- Dysfunction of this UBQLN2-mediated pathway contributes to neurodegenerative diseases.
- Targeting this pathway may offer therapeutic strategies for neurodegeneration.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
Intralumenal Vesicles and Multivesicular Bodies
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

